中文 | English
Return
Total: 2408 , 1/241
Show Home Prev Next End page: GO
MeSH:( Prostatic Neoplasms)

1.Prevalence of prostate cancer following an initial negative MRI-fusion biopsy of the prostate from 2018-2022: A single-center retrospective descriptive cohort

Jose Leuel A. Ongkeko ; Mark C. Cellona

Philippine Journal of Urology 2025;35(1):9-12

2.Regulation of testosterone synthesis by circadian clock genes and its research progress in male diseases.

Gang NING ; Bo-Nan LI ; Hui WU ; Ruo-Bing SHI ; A-Jian PENG ; Hao-Yu WANG ; Xing ZHOU

Asian Journal of Andrology 2025;27(5):564-573

3.Sexual activity in men undergoing ADT for localized prostate cancer: a narrative literature review.

Laeticia CREIDY ; Daniel TAUSSKY ; Frederic POULIOT ; Fred SAAD ; Fabian FALKENBACH

Asian Journal of Andrology 2025;27(5):581-585

4.A propensity score-matched analysis on biopsy methods: enhanced detection rates of prostate cancer with combined cognitive fusion-targeted biopsy.

Bi-Ran YE ; Hui WANG ; Yong-Qing ZHANG ; Guo-Wen LIN ; Hua XU ; Zhe HONG ; Bo DAI ; Fang-Ning WAN

Asian Journal of Andrology 2025;27(4):488-494

5.Sexual function recovery following open and robotic radical prostatectomy: results of an academic penile rehabilitation program.

Michele Di NAUTA ; Ugo Giovanni FALAGARIO ; Anna RICAPITO ; Matteo RUBINO ; Pasquale ANNESE ; Gian Maria BUSETTO ; Luigi CORMIO ; Giuseppe CARRIERI ; Carlo BETTOCCHI

Asian Journal of Andrology 2025;27(6):680-685

6.Recent advances in antibody-drug conjugates for metastatic castration-resistant prostate cancer.

Jiacheng XU ; Yutao MA ; Pengcheng HU ; Jiatao YAO ; Haichao CHEN ; Qi MA

Journal of Zhejiang University. Medical sciences 2025;54(5):685-693

7.PI-RADS v2.1 score combined with PSA density for diagnosis of clinically significant prostate cancer in the PSA grey zone by MRI-TRUS cognitivefusion-guided transperineal targeted prostate biopsy.

Yue LI ; Shan ZHOU ; Jing CHEN ; Fei MAO ; Xiao-Bing NIU ; Li SUN ; Ming XU ; Jin-Tao LIU

National Journal of Andrology 2025;31(1):50-54

8.Irreversible electroporation for the treatment of prostate cancer: An update.

Xiao-Xu JIN ; Xiao-Dong ZHAO ; Song XU

National Journal of Andrology 2025;31(1):76-80

9.Relationship between sterol carrier protein 2 gene and prostate cancer: Based on single-cell RNA sequencing combined with Mendelian randomization.

Jia-Xin NING ; Shu-Hang LUO ; Hao-Ran WANG ; Hui-Min HOU ; Ming LIU

National Journal of Andrology 2025;31(5):403-411

10.Clinical prediction model for patients with early-onset prostate cancer without surgical treatment: Based on the SEER Database.

Han-Dong LIU ; Han-Yu JIA ; Jing WANG ; Li-Ping ZHANG

National Journal of Andrology 2025;31(5):412-420

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 2408 , 1/241 Show Home Prev Next End page: GO